Download the Complete Report Here By Brandon Hornback REX American Resources Corp. (NYSE: REX) continued its long-running winning of streak, making it 21 straight profitable quarters. Ethanol volumes edged higher and operational discipline helped offset softer pricing, reinforcing REX’s position...

Read Exec Edge’s Initiation on REX Here Subscribe to our Weekly Newsletter to Receive All Research Contact: Executives-Edge.com Rayk@capmarketsmedia.com

By Karen Roman Sequana Medical NV (BRU: SEQUA.BR) said it successfully implanted the alfapump device for treatment of recurrent or refractory ascites due to liver cirrhosis in two patients at the University of Pennsylvania. The alfapump is the first FDA-approved...

By Daniella Parra March Bio is developing MB-105, a first-in-class autologous CD5-targeted CAR-T cell therapy for relapsed/refractory T-cell lymphoma and other CD5-positive hematologic malignancies, they said. The company said the therapy employs a proprietary CAR design that enables selective targeting of...

Exec Edge hosted a fireside chat on Dec. 8 from the Nasdaq Marketsite with Chris Searles, co-founder and Chief Executive Officer, and Trevor Smith, co-founder and Chief Technology Officer of DxCheck. The in-person interview was joined by Editor-in-Chief John Jannarone and...

Exec Edge hosted a fireside chat on Dec. 8 at Nasdaq MarketSite with Enzo Villani, Executive Chairman and Chief Investment Officer of AlphaTON Capital Corp. (Nasdaq: ATON). The in-person interview was joined by Editor-in-Chief John Jannarone and they discussed how the...

IPO Edge hosted a fireside chat on Dec. 8 from the Nasdaq Marketsite with Christer Rosen, Chairman and Chief Executive Officer, and Alison Silva, President and Chief Business Officer of Jupiter Neurosciences, Inc. (Nasdaq: JUNS). The in-person interview was joined by...

Exec Edge hosted a fireside chat on Dec. 8 from the Nasdaq Marketsite with Doyl Burkett, Managing Partner and founder of Integrity Growth Partners (IGP). The in-person interview was joined by Editor-in-Chief John Jannarone and they discussed the announcement of IGP’s...

By Daniella Parra ReAlta Life Sciences’ Pegtarazimod demonstrated significant clinical improvement and reduction in inflammatory markers in patients with lower gastrointestinal aGvHD, the company said. Clinical MAGIC stage improvement observed for 6 of 6 patients with steroid-refractory aGvHD, with 4...

IPO Edge hosted a fireside chat on Oct. 2 at Nasdaq MarketSite with Andrew Keys, Co-Founder and Chairman of The Ether Machine (Nasdaq: ETHM). The in-person interview was joined by Editor-in-Chief John Jannarone and they discussed availing public market investors to...